Published in Exp Diabetes Res on May 26, 2010
Stabilized glucagon formulation for bihormonal pump use. J Diabetes Sci Technol (2010) 1.17
Two Cases of Allergy to Insulin in Gestational Diabetes. Endocrinol Metab (Seoul) (2015) 0.85
Controlling the aggregation and rate of release in order to improve insulin formulation: molecular dynamics study of full-length insulin amyloid oligomer models. J Mol Model (2011) 0.84
Adsorption and desorption of bioactive proteins on hydroxyapatite for protein delivery systems. J Drug Deliv (2012) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart (2005) 9.79
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care (2003) 7.80
Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care (2008) 6.53
Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes (2006) 6.52
Continuous glucose monitoring and closed-loop systems. Diabet Med (2006) 4.78
Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med (2008) 3.80
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev (2007) 3.69
Insulin pump therapy: a meta-analysis. Diabetes Care (2003) 3.67
A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther (2005) 3.28
Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care (2004) 3.03
Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients. Diabetes Care (2006) 2.98
Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care (1995) 2.67
Gestational diabetes mellitus. Diabetes Care (2003) 2.22
A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care (2004) 2.20
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med (2006) 1.84
Insulin glulisine complementing basal insulins: a review of structure and activity. Diabetes Technol Ther (2007) 1.80
Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes. Diabet Med (2007) 1.69
A new approach to diabetic control: fuzzy logic and insulin pump technology. Med Eng Phys (2006) 1.63
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care (2005) 1.59
Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther (2008) 1.54
Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obes Metab (2009) 1.49
HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care (2006) 1.48
Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes. Ann Intern Med (2008) 1.47
[Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy]. Gynecol Obstet Fertil (2005) 1.39
Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab (2006) 1.24
Insulin pump therapy: guidelines for successful outcomes. Diabetes Educ (2009) 1.18
Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence. Clin Med Res (2008) 1.17
Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet Med (2005) 1.15
Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics (2004) 1.15
A review of human and analogue insulin trials. Diabetes Res Clin Pract (2006) 1.13
Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up. Diabet Med (2006) 1.09
Insulin glargine and cancer--an unsubstantiated allegation. Diabetes Technol Ther (2009) 1.09
The value of self-monitoring of blood glucose: a review of recent evidence. J Diabetes Complications (2009) 1.07
Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med (2008) 1.07
The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes. Diabetes Care (2001) 1.04
Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE. Diabetes Obes Metab (2007) 1.03
Insulin analogues: an example of applied medical science. Diabetes Obes Metab (2009) 1.02
Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol (2007) 1.02
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev (2007) 1.00
An overview on the development of a bio-artificial pancreas as a treatment of insulin-dependent diabetes mellitus. Med Res Rev (2006) 0.97
Continuous glucose monitoring time series and hypo/hyperglycemia prevention: requirements, methods, open problems. Curr Diabetes Rev (2008) 0.97
Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review. Curr Diabetes Rev (2008) 0.97
Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr Diabetes (2006) 0.95
Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus. Pediatr Diabetes (2007) 0.94
A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes. Diabetes Care (2007) 0.93
The renaissance of insulin pump treatment in childhood type 1 diabetes. Rev Endocr Metab Disord (2006) 0.92
Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis. Diabet Med (2003) 0.92
Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps. J Am Pharm Assoc (2003) (2009) 0.92
Continuous glucose monitoring and external insulin pump: towards a subcutaneous closed loop. Diabetes Metab (2006) 0.91
Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes. Horm Metab Res (2009) 0.89
The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes. Acta Paediatr (2006) 0.89
Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies. Vasc Health Risk Manag (2009) 0.88
The effects of pharmacologic agents for type 2 diabetes mellitus on body weight. Postgrad Med (2008) 0.88
Defining the role of insulin detemir in Basal insulin therapy. Drugs (2007) 0.87
Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol (2000) 0.87
Use of continuous glucose monitoring in patients with type 1 diabetes. Curr Diabetes Rev (2008) 0.86
Clinical practice in type 2 diabetes: After metformin and lifestyle, then what? J Fam Pract (2009) 0.86
Beyond glycemic control: treating the entire type 2 diabetes disorder. Postgrad Med (2009) 0.86
Clinical use of real-time continuous glucose monitoring. Curr Diabetes Rev (2008) 0.86
Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab (2008) 0.85
Real-time glucose sensors in children and adolescents with type-1 diabetes. Horm Res (2008) 0.85
Continuous glucose monitoring: physiological and technological challenges. Curr Diabetes Rev (2008) 0.84
Continuous subcutaneous insulin infusion versus multiple daily injections: modeling predicted benefits in relationship to baseline A1c. Diabetes Care (2005) 0.83
Bioartificial pancreas for the treatment of diabetes. Cell Transplant (2008) 0.83
Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine. Diabet Med (2005) 0.83
Treating type 2 diabetes: how safe are current therapeutic agents? Int J Clin Pract (2009) 0.83
[Quality of life and treatment satisfaction in patients being treated with long-acting insulin analogues]. Dtsch Med Wochenschr (2009) 0.82
Cause of death in infants of women with pregestational diabetes mellitus and the relationship with glycemic control. Postgrad Med (2009) 0.82
Factors correlating with improved A1C in children using continuous subcutaneous insulin infusion. Diabetes Care (2007) 0.81
Consequences of delaying progression to optimal therapy in patients with type 2 diabetes not achieving glycemic goals. South Med J (2009) 0.81
Insulin pump therapy (continuous subcutaneous insulin infusion). Prim Care (2007) 0.81
Past, present, and future of insulin pump therapy: better shot at diabetes control. Mt Sinai J Med (2008) 0.80
New modalities in the treatment of pregnancies complicated by diabetes: drugs and devices. Semin Fetal Neonatal Med (2008) 0.80
Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus. Clin Drug Investig (2008) 0.80
Initiating and intensifying insulin therapy for type 2 diabetes: why, when, and how. Am J Ther (2012) 0.79
Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient. Int J Clin Pract (2008) 0.79
Intensive diabetes therapy and body weight: focus on insulin detemir. Endocrinol Metab Clin North Am (2007) 0.79
Insulin glulisine: a review of its use in the management of diabetes mellitus. Drugs (2009) 0.79
Insulin analogues: action profiles beyond glycaemic control. Arch Physiol Biochem (2008) 0.79
Insulin pump therapy in type 1 diabetes mellitus. J Pediatr (Rio J) (2006) 0.78
Development of insulin delivery systems. Mymensingh Med J (2008) 0.78
Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised? Drugs (2007) 0.78
Treatment of diabetes mellitus using an external insulin pump in clinical practice. Diabetes Metab (2008) 0.78
Prevention of type 2 diabetes mellitus to reduce cardiovascular morbidity and mortality: a review of the evidence. J Clin Hypertens (Greenwich) (2009) 0.76
Insulin glargine and its role in glycaemic management of Type 2 diabetes. Expert Opin Drug Metab Toxicol (2008) 0.76
Individualism and insulin pump therapy. Diabetologia (2008) 0.76
Development and preclinical assessment of a bioartificial pancreas. Swiss Med Wkly (2007) 0.76
Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control. Diabetes Obes Metab (2008) 0.76
Further development of artificial pancreas: blocked by patents? J Diabetes Sci Technol (2008) 0.76
Spotlight on insulin aspart in type 1 and 2 diabetes mellitus. Treat Endocrinol (2003) 0.76